Abstract:Vasopressin triggers the phosphorylation and apical plasma membrane accumulation of aquaporin 2 (AQP2), and it plays an essential role in urine concentration. Vasopressin, acting through protein kinase A, phosphorylates AQP2. However, the phosphorylation state of AQP2 could also be affected by the action of protein phosphatases (PPs). Rat inner medullas (IM) were incubated with calyculin (PP1 and PP2A inhibitor, 50 nM) or tacrolimus (PP2B inhibitor, 100 nM). Calyculin did not affect total AQP2 protein abundanc… Show more
“…AQP2 is one of the most important channel proteins involved in regulating urine concentration, and is located at the apical membrane of principal cells in the collecting duct [14]. The water reabsorption function of AQP2 is mainly regulated by arginine vasopressin (AVP) via increasing intracellular production of cyclic adenosine monophosphatase (cAMP) and further phosphorylation of AQP2 at Ser256 and Ser269 to stimulate the intracellular trafficking of AQP2 to the plasma membrane [15,16,17] (Figure 2). Besides AVP, researchers have demonstrated that activation of bile acid receptor TGR5 and hydrogen sulfide (H 2 S) stimulates the expression of AQP2 via cAMP-protein kinase A (PKA) signaling pathway and attenuates the defection of urinary concentration in mice [18,19].…”
Section: Expression Of Physiological Function Of Aqps In the Kidneymentioning
Aquaporins (AQPs) are a family of highly selective transmembrane channels that mainly transport water across the cell and some facilitate low-molecular-weight solutes. Eight AQPs, including AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7, and AQP11, are expressed in different segments and various cells in the kidney to maintain normal urine concentration function. AQP2 is critical in regulating urine concentrating ability. The expression and function of AQP2 are regulated by a series of transcriptional factors and post-transcriptional phosphorylation, ubiquitination, and glycosylation. Mutation or functional deficiency of AQP2 leads to severe nephrogenic diabetes insipidus. Studies with animal models show AQPs are related to acute kidney injury and various chronic kidney diseases, such as diabetic nephropathy, polycystic kidney disease, and renal cell carcinoma. Experimental data suggest ideal prospects for AQPs as biomarkers and therapeutic targets in clinic. This review article mainly focuses on recent advances in studying AQPs in renal diseases.
“…AQP2 is one of the most important channel proteins involved in regulating urine concentration, and is located at the apical membrane of principal cells in the collecting duct [14]. The water reabsorption function of AQP2 is mainly regulated by arginine vasopressin (AVP) via increasing intracellular production of cyclic adenosine monophosphatase (cAMP) and further phosphorylation of AQP2 at Ser256 and Ser269 to stimulate the intracellular trafficking of AQP2 to the plasma membrane [15,16,17] (Figure 2). Besides AVP, researchers have demonstrated that activation of bile acid receptor TGR5 and hydrogen sulfide (H 2 S) stimulates the expression of AQP2 via cAMP-protein kinase A (PKA) signaling pathway and attenuates the defection of urinary concentration in mice [18,19].…”
Section: Expression Of Physiological Function Of Aqps In the Kidneymentioning
Aquaporins (AQPs) are a family of highly selective transmembrane channels that mainly transport water across the cell and some facilitate low-molecular-weight solutes. Eight AQPs, including AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7, and AQP11, are expressed in different segments and various cells in the kidney to maintain normal urine concentration function. AQP2 is critical in regulating urine concentrating ability. The expression and function of AQP2 are regulated by a series of transcriptional factors and post-transcriptional phosphorylation, ubiquitination, and glycosylation. Mutation or functional deficiency of AQP2 leads to severe nephrogenic diabetes insipidus. Studies with animal models show AQPs are related to acute kidney injury and various chronic kidney diseases, such as diabetic nephropathy, polycystic kidney disease, and renal cell carcinoma. Experimental data suggest ideal prospects for AQPs as biomarkers and therapeutic targets in clinic. This review article mainly focuses on recent advances in studying AQPs in renal diseases.
“…In addition to the involvement of PP2A in AQP2 regulation, protein phosphatase 2B (PP2B), one of components of AKAPs-containing multiple complex has also been proposed to dephosphorylate endosome-bounded AQP2 (44). A recent study demonstrated that multiple phosphatases are involved in the subcellular localization of phosphorylated AQP2, and particularly PP1/PP2A plays a role in the AQP2 phosphorylation and AQP2 expression in the apical plasma membrane (116). Comprehensive understanding of the effects of multiple kinases under different conditions, such as activity and specificity against each phosphorylation site of AQP2 and the interaction with other proteins, could provide information for better understanding of the phosphorylationmediated AQP2 trafficking.…”
Section: Role Of Phosphatidylinositol-3-kinase/akt Gsk3 and Cyclin-mentioning
The kidney collecting duct is an important renal tubular segment for regulation of body water homeostasis and urine concentration. Water reabsorption in the collecting duct principal cells is controlled by vasopressin, a peptide hormone that induces the osmotic water transport across the collecting duct epithelia through regulation of water channel proteins aquaporin-2 (AQP2) and aquaporin-3 (AQP3). In particular, vasopressin induces both intracellular translocation of AQP2-bearing vesicles to the apical plasma membrane and transcription of the Aqp2 gene to increase AQP2 protein abundance. The signaling pathways, including AQP2 phosphorylation, RhoA phosphorylation, intracellular calcium mobilization, and actin depolymerization, play a key role in the translocation of AQP2. This review summarizes recent data demonstrating the regulation of AQP2 as the underlying molecular mechanism for the homeostasis of water balance in the body.
“…Aldosterone increases calcineurin activity in rat cortical collecting ducts through an MR-dependent but transcription-independent mechanism [11]. Our published data show that inhibiting calcineurin alters the phosphorylation and the activity of the urea transporter UT-A1 in the IMCD [12,13].…”
Section: Introductionmentioning
confidence: 84%
“…Previous studies show aldosterone increases urine production and decreases apical AQP2 expression in rats with diabetes insipidus, suggesting that aldosterone may decrease vasopressinstimulated osmotic water permeability [13,22]. There are some sex-specific differences in blood pressure control and water homeostasis (reviewed in [29]).…”
Aldosterone indirectly regulates water reabsorption in the distal tubule by regulating sodium reabsorption. However, the direct effect of aldosterone on vasopressin-regulated water and urea permeability in the rat inner medullary collecting duct (IMCD) has not been tested. We investigated whether aldosterone regulates osmotic water permeability in isolated perfused rat IMCDs. Adding aldosterone (500 nM) to the bath significantly decreased osmotic water permeability in the presence of vasopressin (50 pM) in both male and female rat IMCDs. Aldosterone significantly decreased aquaporin-2 (AQP2) phosphorylation at S256 but did not change it at S261. Previous studies show that aldosterone can act both genomically and non-genomically. We tested the mechanism by which aldosterone attenuates osmotic water permeability. Blockade of gene transcription with actinomycin D did not reverse aldosterone-attenuated osmotic water permeability. In addition to AQP2, the urea transporter UT-A1 contributes to vasopressin-regulated urine concentrating ability. We tested aldosterone-regulated urea permeability in vasopressin-treated IMCDs. Blockade of gene transcription did not reverse aldosterone-attenuated urea permeability. In conclusion, aldosterone directly regulates water reabsorption through a non-genomic mechanism. Aldosterone-attenuated water reabsorption may be related to decreased trafficking of AQP2 to the plasma membrane. There may be a sex difference apparent in the inhibitory effect of aldosterone on water reabsorption in the inner medullary collecting duct. This study is the first to show a direct effect of aldosterone to inhibit vasopressin-stimulated osmotic water permeability and urea permeability in perfused rat IMCDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.